Jane Street’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-454,619
| Closed | -$17.9M | – | 9751 |
|
|
2023
Q2 | $17.9M | Buy |
454,619
+86,523
| +24% | +$3.05M | 0.01% | 1322 |
|
|
2023
Q1 | $8.96M | Buy |
368,096
+329,654
| +858% | +$7.22M | ﹤0.01% | 1759 |
|
|
2022
Q4 | $823K | Buy |
38,442
+4,196
| +12% | +$89.6K | ﹤0.01% | 5280 |
|
|
2022
Q3 | $614K | Sell |
34,246
-104,329
| -75% | -$1.37M | ﹤0.01% | 6305 |
|
|
2022
Q2 | $1.33M | Buy |
+138,575
| New | +$1.74M | ﹤0.01% | 4949 |
|
|
2022
Q1 | – | Sell |
-93,601
| Closed | -$1.38M | – | 11317 |
|
|
2021
Q4 | $1.56M | Sell |
93,601
-7,414
| -7% | -$122K | ﹤0.01% | 4978 |
|
|
2021
Q3 | $1.64M | Buy |
101,015
+65,765
| +187% | +$716K | ﹤0.01% | 4897 |
|
|
2021
Q2 | $222K | Buy |
35,250
+16,656
| +90% | +$107K | ﹤0.01% | 8659 |
|
|
2021
Q1 | $115K | Sell |
18,594
-132,794
| -88% | -$806K | ﹤0.01% | 8583 |
|
|
2020
Q4 | $1.05M | Buy |
+151,388
| New | +$969K | ﹤0.01% | 4582 |
|
|
2020
Q3 | – | Sell |
-30,755
| Closed | -$157K | – | 8180 |
|
|
2020
Q2 | $157K | Sell |
30,755
-27,345
| -47% | -$114K | ﹤0.01% | 6522 |
|
|
2020
Q1 | $200K | Buy |
+58,100
| New | +$340K | ﹤0.01% | 4652 |
|
|
2019
Q1 | – | Sell |
-19,069
| Closed | -$23K | – | 5829 |
|
|
2018
Q4 | $23K | Buy |
+19,069
| New | +$37K | ﹤0.01% | 4782 |
|
|
2018
Q1 | – | Sell |
-17,093
| Closed | -$53K | – | 5592 |
|
|
2017
Q4 | $53K | Buy |
+17,093
| New | +$48K | ﹤0.01% | 4421 |
|
|
2017
Q3 | – | Sell |
-110,963
| Closed | -$284K | – | 5230 |
|
|
2017
Q2 | $284K | Buy |
+110,963
| New | +$302K | ﹤0.01% | 3657 |
|
|
2017
Q1 | – | Sell |
-22,680
| Closed | -$110K | – | 4827 |
|
|
2016
Q4 | $110K | Buy |
22,680
+12,180
| +116% | +$362K | ﹤0.01% | 3855 |
|
|
2016
Q3 | $484K | Buy |
+10,500
| New | +$592K | ﹤0.01% | 2809 |
|
|
2016
Q1 | – | Sell |
-4,152
| Closed | -$326K | – | 4780 |
|
|
2015
Q4 | $326K | Sell |
4,152
-5,864
| -59% | -$339K | ﹤0.01% | 2995 |
|
|
2015
Q3 | $406K | Buy |
+10,016
| New | +$531K | ﹤0.01% | 2509 |
|
|
2014
Q3 | – | Sell |
-5,879
| Closed | -$249K | – | 3198 |
|
|
2014
Q2 | $249K | Buy |
+5,879
| New | +$216K | ﹤0.01% | 1995 |
|
Jane Street's ISEE Position: Q3 2023 in Review
Jane Street sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 454,619 shares — an estimated $17.9M sold.
Jane Street first reported a position in ISEE in Q2 2014 and held it in 20 quarters. The position peaked at $17.9M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Jane Street reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Jane Street sold 454,619 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $17.9M.
- Jane Street first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 20 quarters.
- Jane Street's IVERIC bio, Inc. Common Stock position peaked at $17.9M in Q2 2023.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.